Already a AI Vertical member? Login to access this report free.
Report Highlights
This report provides an outlook of artificial intelligence (AI) impact on the global market for monoclonal antibodies (mAbs) in oncology. It highlights major adoption trends of AI and machine learning-based algorithms across the key geographic regions from North America to the Asia-Pacific and Europe. The report covers disruptions caused across several key industry verticals and the impact on the various stages of global supply chain.
Report Includes
- Impact analysis of artificial intelligence on the global monoclonal antibodies in oncology market
- Insights of the use cases/case studies for AI implementation related to monoclonal antibodies in oncology
- Understanding of AI adoption trends across the major geographic regions
- Review of AI disruption trends across the key industry verticals
- Impact of AI on various stages of the value chain
- Analysis of the companies’ market spendings and forecasting analysis, and a VC investment outlook
Report Scope
Artificial intelligence (AI) is massively transforming the global monoclonal antibodies (mAbs) in oncology market by accelerating and de-risking the development pipeline. Deep learning (DL) and generative models enable rapid screening of molecular libraries, identifying and designing novel antibody sequences with optimized properties for drug safety and efficacy. This in silico precision reduces reliance on traditional experimental methods, reducing development time and cost. AI is also increasingly used for predictive modeling to assess an antibody’s developability and to personalize cancer treatment by predicting a patient’s response to specific mAb therapies.
Major companies operating within the monoclonal antibodies in oncology industry, including Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Co., and AstraZeneca, are at the forefront of AI integration in R&D and drug manufacturing.
This report provides a global outlook of the AI impact on monoclonal antibodies in oncology. It also highlights major AI adoption and disruption trends across the regions.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Recent Reports
AI Impact on Oligonucleotides Market - BCC Pulse Report
This report provides an outlook of artificial intelligence (AI) impact on the global oligonucleotides market. It highlights major adoption trends of AI and machine learning (ML)-based algorithms across the key geographic regions from North America to the Asia-Pacific and Europe. The report covers disruptions caused across several key industry verticals and the impact on the various stages of the value chain analysis.
AI Impact on Fuel Cells for Residential, Commercial and Military Power Market - BCC Pulse Report
Artificial Intelligence (AI) is changing how fuel cells and next-generation fuel cell stacks are developed and optimized by interpreting massive data sets, replicating complex chemical reactions and enabling better material and structural design. AI models help predict fuel cell degradation, improve power density, lower production and R&D costs, driving adoption in fuel cell components and advanced materials.
AI Impact on Monoclonal Antibodies in Oncology Market - BCC Pulse Report
This report provides an outlook of artificial intelligence (AI) impact on the global market for monoclonal antibodies (mAbs) in oncology. It highlights major adoption trends of AI and machine learning-based algorithms across the key geographic regions from North America to the Asia-Pacific and Europe. The report covers disruptions caused across several key industry verticals and the impact on the various stages of global supply chain.
AI Use Case Analysis: Global Outlook
This report provides a comprehensive analysis of artificial intelligence (AI) use cases across technologies, industries, and organizational contexts. The study presents detailed qualitative insights, focusing on how AI applications are evolving, scaling, and creating business value. The scope covers AI use cases across key technology domains, major industry verticals, and startup ecosystems, offering structured visibility into adoption patterns, maturity levels, and real-world implementation scenarios.
Global AI Investment Trends & Spending Outlook
The report analyzes global AI investment growth, focusing on corporate and private funding, mergers and acquisitions, and venture capital trends. It also compares regional VC investment patterns worldwide.
Top Trending Reports
Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing
The global market for genetic modification therapies is estimated to grow from $14.8 billion in 2025 to reach $32.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.8% from 2025 through 2030.
Carbon Fiber: Global Markets
The global market for carbon fiber was valued at $4.9 billion in 2024 and is estimated to increase from $5.3 billion in 2025 to reach $8.2 billion by 2030, at a compound annual growth rate (CAGR) of 9.1% from 2025 through 2030.
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.
Global Oncology Biosimilars Market
The global market for oncology biosimilars is estimated to grow from $9.6 billion in 2025 and projected to reach $17.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2030.
Sleep Aids: Technologies and Global Markets
The global market for sleep aid technologies is estimated to grow from $103.5 billion in 2025 to reach $136 billion by 2030, at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More